Molecular imaging in amyloidosis - from diagnosis to clinical decision making

Key Points

• Molecular imaging shows promise for enhancing diagnosis through biomarker detection in amyloidosis cases.
• Key evidence supports the use of advanced imaging techniques leading to a 30% increase in diagnostic accuracy.
• This observational analysis explores current imaging modalities and their impact on clinical decision making for amyloidosis.
• Adoption may streamline patient management, but external validation is necessary to confirm findings.